SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-14-000039
Filing Date
2014-05-09
Accepted
2014-05-09 12:07:20
Documents
12
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q valeantq12014.htm 10-Q 1671905
2 EXHIBIT - 10.1 exhibit101.htm EX-10.1 75688
3 EXHIBIT - 31.1 exhibit311.htm EX-31.1 14194
4 EXHIBIT - 31.2 exhibit312.htm EX-31.2 14317
5 EXHIBIT - 32.1 exhibit321.htm EX-32.1 8541
6 EXHIBIT - 32.2 exhibit322.htm EX-32.2 8521
  Complete submission text file 0000885590-14-000039.txt   14937951

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vrx-20140331.xml EX-101.INS 2964757
8 XBRL TAXONOMY EXTENSION SCHEMA vrx-20140331.xsd EX-101.SCH 70872
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrx-20140331_cal.xml EX-101.CAL 114688
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrx-20140331_lab.xml EX-101.LAB 928431
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrx-20140331_pre.xml EX-101.PRE 556964
12 XBRL TAXONOMY EXTENSION DEFINITION DOCUMENT vrx-20140331_def.xml EX-101.DEF 401221
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 14827757
SIC: 2834 Pharmaceutical Preparations